Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years

被引:89
作者
Chen, Jian-Jun [1 ,2 ]
Wang, Xi-Mo [1 ,2 ]
Liu, Xing-Qiang [2 ]
Li, Wen [2 ]
Dong, Mo [2 ]
Suo, Zong-Wu [2 ]
Ding, Po [2 ]
Li, Yue [2 ]
机构
[1] Tianjin Nankai Hosp, Dept Gastroenterol, Tianjin 300100, Peoples R China
[2] Peoples Hosp Tianjin, Dept Gastroenterol, Tianjin 300121, Peoples R China
关键词
Endoscopic retrograde cholangiopancreatography; Pancreatitis; Risk factors; Systematic review; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; BILIARY SPHINCTEROTOMY; PROSPECTIVE MULTICENTER; ODDI DYSFUNCTION; COMPLICATIONS; SOMATOSTATIN; METAANALYSIS; PROPHYLAXIS; GABEXATE; STENTS;
D O I
10.1186/2047-783X-19-26
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common and most severe complication associated with diagnostic and therapeutic ERCP. A multivariate analysis of risk factors for PEP is essential for identifying patients at high risk and subsequently choosing other suitable diagnoses. Methods: Pertinent publications were identified through systematic searches of MEDLINE, Elsevier, and Springer; we performed a systematic review of 12 clinical studies published in the past ten years, selected out of 451 reviewed articles, in which risk factors for pancreatitis were identified. Seven probable risk factors were evaluated, and outcomes expressed in the case of dichotomous variables, as an odds ratio (OR) (with a 95% confidence interval, 95% CI). Results: When the risk factors were analyzed, the OR for female gender was 1.40 (95% CI 1.24 to 1.58); the OR for previous PEP was 3.23 (95% CI 2.48 to 4.22); the OR for previous pancreatitis was 2.00 (95% CI 1.72 to 2.33); the OR for endoscopic sphincterotomy was 1.42 (95% CI 1.14 to 1.78); the OR for precut sphincterotomy was 2.11 (95% CI 1.72 to 2.59); the OR for Sphincter of Oddi dysfunction was 4.37 (95% CI 3.75 to 5.09); and the OR for non-prophylactic pancreatic duct stent was 2.10 (95% CI 1.63 to 2.69). Conclusions: It appears that female gender, previous PEP, previous pancreatitis, endoscopic sphincterotomy, precut sphincterotomy, Sphincter of Oddi dysfunction, and non-prophylactic pancreatic duct stent are the risk factors for post-ERCP pancreatitis.
引用
收藏
页数:7
相关论文
共 31 条
[1]   Mechanism of pancreatitis caused by ERCP [J].
Akashi, R ;
Kiyozumi, T ;
Tanaka, T ;
Sakurai, K ;
Oda, Y ;
Sagara, K .
GASTROINTESTINAL ENDOSCOPY, 2002, 55 (01) :50-54
[2]   Complications of ERCP [J].
Anderson, Michelle A. ;
Fisher, Laurel ;
Jain, Rajeev ;
Evans, John A. ;
Appalaneni, Vasundhara ;
Ben-Menachem, Tamir ;
Cash, Brooks D. ;
Decker, G. Anton ;
Early, Dayna S. ;
Fanelli, Robert D. ;
Fisher, Deborah A. ;
Fukami, Norio ;
Hwang, Joo Ha ;
Ikenberry, Steven O. ;
Jue, Terry L. ;
Khan, Khalid M. ;
Krinsky, Mary Lee ;
Malpas, Phyllis M. ;
Maple, John T. ;
Sharaf, Ravi N. ;
Shergill, Amandeep K. ;
Dominitz, Jason A. .
GASTROINTESTINAL ENDOSCOPY, 2012, 75 (03) :467-473
[3]   Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial [J].
Andriulli, A ;
Clemente, R ;
Solmi, L ;
Terruzzi, V ;
Suriani, R ;
Sigillito, A ;
Leandro, G ;
Leo, P ;
De Maio, G ;
Perri, F .
GASTROINTESTINAL ENDOSCOPY, 2002, 56 (04) :488-495
[4]   Incidence rates of post-ERCP complications: A systematic survey of prospective studies [J].
Andriulli, Angelo ;
Loperfido, Silvano ;
Napolitano, Grazia ;
Niro, Grazia ;
Valvano, Maria Rosa ;
Spirito, Fulvio ;
Pilotto, Alberto ;
Forlano, Rosario .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08) :1781-1788
[5]   Prophylaxis of ERCP-Related Pancreatitis: A Randomized, Controlled Trial of Somatostatin and Gabexate Mesylate [J].
Andriulli, Angelo ;
Solmi, Luigi ;
Loperfido, Silvano ;
Leo, Pietro ;
Festa, Virginia ;
Belmonte, Angelo ;
Spirito, Fulvio ;
Silla, Michele ;
Forte, Giovambattista ;
Terruzzi, Vittorio ;
Marenco, Giorgio ;
Ciliberto, Enrico ;
Sabatino, Antonio ;
Monica, Fabio ;
Magnolia, Maria Rita ;
Perri, Francesco .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (08) :713-718
[6]   Functional gallbladder and sphincter of Oddi disorders [J].
Behar, Jose ;
Corazziari, Enrico ;
Guelrud, Moises ;
Hogan, Walter ;
Sherman, Stuart ;
Toouli, James .
GASTROENTEROLOGY, 2006, 130 (05) :1498-1509
[7]   Is endoscopic balloon dilation for removal of bile duct stones associated with an increased risk for pancreatitis or a higher rate of hyperamylasemia? [J].
Bergman, JJGHM ;
van Berkel, AM ;
Bruno, MJ ;
Fockens, P ;
Rauws, EAJ ;
Tijssen, JGP ;
Tytgat, GNJ ;
Huibregtse, K .
ENDOSCOPY, 2001, 33 (05) :416-420
[8]   Risk factors for post-ERCP pancreatitis: A prospective multicenter study [J].
Cheng, CL ;
Sherman, S ;
Watkins, JL ;
Barnett, J ;
Freeman, M ;
Geenen, J ;
Ryan, M ;
Parker, H ;
Frakes, JT ;
Fogel, EL ;
Silverman, WB ;
Dua, KS ;
Aliperti, G ;
Yakshe, P ;
Uzer, M ;
Jones, W ;
Goff, J ;
Lazzell-Pannell, L ;
Rashdan, A ;
Temkit, M ;
Lehman, GA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01) :139-147
[9]   Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review [J].
Choudhary, Abhishek ;
Bechtold, Matthew L. ;
Arif, Murtaza ;
Szary, Nicholas M. ;
Puli, Srinivas R. ;
Othman, Mohamed O. ;
Pais, Wilson P. ;
Antillon, Mainor R. ;
Roy, Praveen K. .
GASTROINTESTINAL ENDOSCOPY, 2011, 73 (02) :275-282
[10]   Quality indicators, including complications, of ERCP in a community setting: a prospective study [J].
Colton, Joshua B. ;
Curran, Colleen C. .
GASTROINTESTINAL ENDOSCOPY, 2009, 70 (03) :457-467